Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines.

Article Details

Citation

Dizdar O, Dede DS, Bulut N, Altundag K

Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines.

Breast Cancer Res Treat. 2008 Jan;107(2):303. Epub 2007 Mar 10.

PubMed ID
17351742 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
DasatinibMast/stem cell growth factor receptor KitProteinHumans
Yes
Antagonist
Details